Shares of Aquestive Therapeutics jumped more than 11% in after-hours trading Thursday after CEO Dan Barber said the company’s oral epinephrine film, Anaphylm, could become a “blockbuster” drug with as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback